Aptamer-Enhanced Surface Decontamination: A Novel Approach for Neutralizing Peanut Allergens and Preventing Cell-Degranulation Read our newly published article on groundbreaking research into an aptamer-based spray that neutralizes peanut allergens on [...]
Cytokine Testing: A Game Changer for Clinical Trials Multiplex cytokine (Interferons Viral Replication, Broad-Spectrum Protease Inhibitor, Growth Factors, Chemokines, Interleukins, TNF Ligand Superfamily Member, Epithelial Cell Cytokine, IL-6 Subfamily Cytokine, [...]
Here’s why this award is significant: 1. Recognition of Scientific Excellence This award highlights researchers or organizations that have made outstanding contributions to innovation in genomic or transcriptomic sequencing. Technologies [...]
Article in D Magazine The Frisco Physician Growing Hypo-Allergenic Peanuts Ayass Bioscience made headlines during COVID with an advanced lab and has now turned its molecular medicine expertise to preventing [...]
Published: 30 December 2022 Highly efficacious and safe neutralizing DNA aptamer of SARS-CoV-2 as an emerging therapy for COVID-19 disease Contributors: Mohamad Ammar Ayass, Trivendra Tripathi, Natalya Griko, Victor Pashkov, [...]
We need donors that are 18 and older to establish the ranges for a new assay to detect 65 cytokines from serum samples. The assay is one of a kind [...]
Ayass BioScience, LLC participated in Annual Meeting of The American Association of Immunologists in Oregon Convention Center Portland, Oregon, May 6-10 2022.
The Ayass Bioscience family is celebrating its sixth anniversary this year. The company has grown over the years from the dreams of our founder and CEO, Dr. Ayass, into one [...]
Testing for COVID-19 has gone up significantly in the last month, and consequently positive cases have risen as well and more Omicron variants were identified at our laboratory. Given the [...]
The Texas State Health Department has confirmed the findings of a Ayass BioScience, LLC laboratory that detected two North Texas cases of the omicron variant.
Ayass BioScience, LLC has detected the first two cases of the OMICRON variant in the DFW Metroplex using Next Generation Sequencing (NGS). This is a part of our [...]
